Kura Oncology Shares Jump 6% After $30M Milestone Payment for Cancer Drug Trial

Kura Oncology stock rises 6% in premarket trading after receiving $30 million milestone payment from Kyowa Kirin for Phase 3 cancer drug trial advancement.